CLINICAL_TRIALS
trial_result
· 2020-09-25
Clinical Trial Update: A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema [Phase 2]
Summary
Phase 2 trial assessing faricimab in center-involving diabetic macular edema has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2020-09-25